S&P 500 7412.84 +0.19%
NASDAQ 26274.12 +0.10%
TASI 11127.51 -0.28%
Oil (WTI) 101.20 +3.19%
Oil (Brent) 107.08 +2.75%
VIX 18.87 +2.67%
Gold 4710.30 -0.39%
USD/SAR 3.75 +0.01%

Zoetis Inc.

ZTS · Healthcare · · USD
76.67 USD
0.00 (-7.44%)
● Updated 2026-05-12 12:49 Saudi Time ↻ Refresh
Short-term Mid-term Long-term

Fahodi Score BUY Long-term (Investment)

65
/ 100
Technical 33
Trend & RS 16
Momentum 0
Fundamental 83
Macro 65
Liquidity 85
ComponentScoreWeight
Technical 33.3 10%
Trend & RS 16.2 10%
Momentum 0.0 5%
Fundamental 83.3 40%
Macro 65.1 15%
Liquidity 85.1 20%

Trade Setup

Entry 76.67
Stop Loss 66.99 (12.6%)
Target 1 (1:1) 86.35 (+12.6%)
Target 2 (2:1) 96.03 (+25.2%)
ATR(14) 4.84 (6.3%)
Risk per Share 9.68
Reward:Risk 2:1

ATR-based levels. Adjust for support/resistance zones.

Factor Profile

Factor Score Z Bar
Value 52.7 +0.11
Momentum 0.0 -2.00
Quality 84.0 +1.36
Composite 45.5

Quality Scores

Piotroski F-Score 6 /9 — Average
1. Positive Net Income 2. Positive Roa 3. Positive Cfo 4. Quality Earnings 5. Lower Leverage 6. Higher Liquidity 7. No Dilution 8. Higher Gross Margin 9. Higher Asset Turnover
Altman Z-Score 5.03 Safe Zone
Distress <1.81Grey 1.81–2.99>2.99 Safe

Valuation vs Peers Fair Value

MetricStockSectorvs Peers
P/E Ratio 12.6 22.0 -43% below
P/B Ratio 9.8 4.0 Above
Dividend Yield 2.8% 1.5% Above avg

Comparing against Healthcare median multiples.

Intrinsic Value (DCF) Fairly Valued

Intrinsic Value
78.30
vs
Market Price
76.67
Upside
+2.1%
Margin of Safety +2.1%
Stage 1 PV (5yr FCF)8,634,679,520
Terminal Value PV24,189,401,240
Total Enterprise Value32,824,080,760

Assumptions

Base FCF2,045,833,216
Growth Rate (5yr)2.9%
Terminal Growth2.5%
Discount Rate (WACC)9.0%

2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.

Position Sizing — Kelly Criterion

4.5%
Recommended Size
42.73%
Full Kelly
21.36%
Half Kelly
5.0%
Max Cap (Moderate)

Kelly inputs derived from quant score 65/100. Estimated win rate 60%, avg win 8.9%, avg loss 3.7%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.

BEAR Regime: BEAR (20% confidence) — position size reduced 10%

Signal Summary SELL

2
Bullish Signals
4
Bearish Signals
12.16
RSI(14)
-7.6438
MACD

Relative Strength (RS) WEAK RS

3
/ 99
RS Rating
O'Neil filter: <80
RS vs SPY ↓ FALLING (-46.3% vs SPY 3M)
RS vs Sector UNDERPERFORMING (Healthcare)
RS New High No (50d since high)
Sector Outperformance -37.0% (3M)
RS Line — stock / SPY (90 bars)
← older newer →
RS vs SPY 50-day SMA of RS
WEAK RS: Underperformer — the stock is lagging the market. Avoid until RS trend reverses upward.

Technical Indicators

IndicatorValueSignal
Rsi 12.16 OVERSOLD
Macd -7.6438 BEARISH
Ma Cross 115.71 / 129.54 DEATH CROSS
Trend Short BELOW SMA50
Trend Long BELOW SMA200
Bollinger LOWER BAND
Volume 2.49x HIGH

Key Levels

LevelPrice
52-Week High172.23
Bollinger Upper137.96
SMA(200)129.54
SMA(50)115.71
SMA(20)111.66
Current Price76.67
Bollinger Lower85.36
52-Week Low76.38
ATR(14)4.84

Advanced Technical Analysis

Click to expand

Wyckoff Phase & Volume Spread Analysis

Wyckoff Phase

MARKDOWN Confidence
64%
Selling Climax Sign of Weakness
Acc: 2.0  |  Dist: 0.0  |  Markup: 0.0  |  Markdown: 3.5

Volume Spread Analysis (last 5 bars)

DateSignalVolDescription
2026-05-05 Normal 0.53x Normal bar — no special VSA pattern
2026-05-06 Normal 0.84x Normal bar — no special VSA pattern
2026-05-07 Stopping Volume 4.77x High volume down-bar closing near low — potential climax (Stopping Volume)
2026-05-08 Stopping Volume 2.74x High volume down-bar closing near low — potential climax (Stopping Volume)
2026-05-11 Stopping Volume 2.49x High volume down-bar closing near low — potential climax (Stopping Volume)

Ichimoku Cloud BEARISH

LineValueStatus
Tenkan-sen (9) 96.31 Below Kijun
Kijun-sen (26) 99.85 Base line
Senkou A 98.08 Leading span A
Senkou B 104.05 Leading span B
Cloud 98.08 – 104.05 Bearish (Red)
Price vs Cloud 76.67 Below Cloud
Chikou Span 117.75 Bearish
Alignment Score 0/4 BEARISH

TTM Squeeze & Divergences

TTM Squeeze

SQUEEZE OFF No squeeze Momentum: BEARISH
BB: 85.36 – 137.96  |  KC: 105.03 – 118.3

Divergences (last 60 bars)

No significant divergences detected in the last 60 bars.

Anchored VWAP

VWAP: 111.85 Anchor: 2026-02-13 (52w Low) BELOW AVWAP -31.4%

Heikin-Ashi Trend

BEARISH Full data via /api/advanced/ZTS

Valuation

MetricValue
Market Cap32.14B
P/E (TTM)12.57
Forward P/EN/A
P/B9.78
EPS6.10

Financial Health

MetricValue
Revenue Growth2.9%
Profit Margin28.0%
ROE67.7%
Debt/Equity286.24
Current Ratio3.15
Dividend Yield2.8%
Payout RatioN/A
Beta0.86

Trading Data

76.67
Open
76.67
Day High
76.67
Day Low
15.59M
Volume (3.3x avg)

Recent News (8)

ZTS Q1 Deep Dive: Guidance Cut as Competition and Consumer Headwinds Weigh on Performance
StockStory · 2026-05-11
Sector Update: Healthcare Stocks Softer Late Afternoon
MT Newswires · 2026-05-11
Zoetis Stock: Analyst Estimates & Ratings
Barchart · 2026-05-11
Zoetis Inc. Just Missed Earnings - But Analysts Have Updated Their Models
Simply Wall St. · 2026-05-09
Sector Update: Healthcare Stocks Lower Late Afternoon
MT Newswires · 2026-05-08
Company News for May 8, 2026
Zacks · 2026-05-08
Zoetis (ZTS) Is Down 24.1% After Cutting 2026 Guidance On Softer U.S. Pet Demand – Has The Bull Case Changed?
Simply Wall St. · 2026-05-08
Zoetis Inc. Q1 2026 Earnings Call Summary
Moby · 2026-05-08

Price Chart (90 Days)

Candlesticks (green=up, red=down) SMA 20 SMA 50 Bollinger Bands (upper/lower) Volume (green=buying, red=selling)
Powered by Fahodi Methodology. This is analytical output, not financial advice. Always do your own due diligence.  ·  Pipeline status  ·  Data: —